Australia
June 8, 2022
The Gene Technology Regulator is assessing an application from BASF Australia Ltd for commercial cultivation of Indian mustard genetically modified (GM) for herbicide tolerance in all agricultural cropping areas of Australia. The GM Indian mustard and its products would enter general commerce, including use in human food and animal feed.
The Regulator has prepared a Risk Assessment and Risk Management Plan (RARMP) for this application and welcomes written submissions on issues relating to the protection of human health and safety and the environment prior to making a decision on whether or not to issue the licence. The consultation RARMP and related information can be obtained via the contacts below. Submissions should reference DIR 190 and be received by 3 August 2022.
Office of the Gene Technology Regulator
MDP 54 GPO Box 9848 CANBERRA ACT 2601
Telephone: 1800 181 030
OGTR Website
E-mail: ogtr@health.gov.au
Licence details
Licence number: DIR 190
Licence status: Application under evaluation
Category: Agricultural
Release: Commercial
Organisation: BASF Australia Ltd
Date application received: 25 November 2021
RARMP open for public consultation: 8 June 2022
RARMP closed for public consultation: 3 August 2022
Documents
Licence application - invitation to comment
An invitation for written submissions from the public on the consultation version of the Risk Assessment and Risk Management Plan. It also explains how the public can access the consultation documents and the due date for submissions.
Licence application - Q&A
FAQs on the licence application and a brief outline of the assessment and public consultation processes.
Risk assessment and risk management plan (consultation) - summary
A summary of the Risk Assessment and Risk Management Plan prepared as part of the assessment of this application. It provides a brief description of the licence application, the risk assessment and risk management plan.
Risk assessment and risk management plan (consultation) - full version
A draft risk assessment and management plan prepared to support the Regulator's decision. It describes the GMO(s) and proposed work with the GMO(s) and provides an assessment of potential risks posed by the GMO(s).